Your browser doesn't support javascript.
loading
An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet's disease in long-term remission.
Ida, Yasutsugu; Takeuchi, Masaki; Ishihara, Mami; Shibuya, Etsuko; Yamane, Takahiro; Hasumi, Yukiko; Kawano, Shigeru; Kimura, Ikuko; Mizuki, Nobuhisa.
Affiliation
  • Ida Y; Yokohama Minami Kyosai Hospital, Yokohama, Japan.
  • Takeuchi M; Department of Ophthalmology, Yokohama City University, Yokohama, Japan.
  • Ishihara M; Department of Ophthalmology, Yokohama City University, Yokohama, Japan. takeuchi@yokohama-cu.ac.jp.
  • Shibuya E; Department of Ophthalmology, Yokohama City University, Yokohama, Japan.
  • Yamane T; Department of Ophthalmology, Yokohama City University, Yokohama, Japan.
  • Hasumi Y; Department of Ophthalmology, Yokohama City University, Yokohama, Japan.
  • Kawano S; Department of Ophthalmology, Yokohama City University, Yokohama, Japan.
  • Kimura I; Yokohama Minami Kyosai Hospital, Yokohama, Japan.
  • Mizuki N; Department of Ophthalmology, Yokohama City University, Yokohama, Japan.
Jpn J Ophthalmol ; 65(6): 843-848, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34586526

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveitis / Behcet Syndrome Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Jpn J Ophthalmol Year: 2021 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveitis / Behcet Syndrome Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Jpn J Ophthalmol Year: 2021 Document type: Article Affiliation country: Japan